172 related articles for article (PubMed ID: 24990598)
1. Antipsychotics for behavioral and psychiatric symptoms of dementia: a reaudit in a specialist inpatient service.
Haw C; Stoffels M; Purkayastha DD; Sudad S
Int Psychogeriatr; 2015 Jan; 27(1):171-2. PubMed ID: 24990598
[No Abstract] [Full Text] [Related]
2. Antipsychotics in dementia: prevalence and quality of antipsychotic drug prescribing in UK mental health services.
Barnes TR; Banerjee S; Collins N; Treloar A; McIntyre SM; Paton C
Br J Psychiatry; 2012 Sep; 201(3):221-6. PubMed ID: 22790679
[TBL] [Abstract][Full Text] [Related]
3. Professional consensus on the treatment of agitation, aggressive behaviour, oppositional behaviour and psychotic disturbances in dementia.
Benoit M; Arbus C; Blanchard F; Camus V; Cerase V; Clement JP; Fremont P; Guerin O; Hazif Thomas C; Jeanblanc F; Lafont C; Moreaud O; Pedra M; Poncet M; Richard Harston S; Rigaud AS; Sotto Martin ME; Touchon J; Vellas B; Fitten LJ; Robert PH
J Nutr Health Aging; 2006; 10(5):410-5. PubMed ID: 17066213
[No Abstract] [Full Text] [Related]
4. Management of non-cognitive symptoms associated with dementia.
Drug Ther Bull; 2014 Oct; 52(10):114-8. PubMed ID: 25298119
[TBL] [Abstract][Full Text] [Related]
5. Antipsychotic drugs predominate in pharmacotherapy of nursing home residents with dementia.
Huber M; Kölzsch M; Rapp MA; Wulff I; Kalinowski S; Bolbrinker J; Hofmann W; Scholze J; Dräger D; Kreutz R
Pharmacopsychiatry; 2012 Jul; 45(5):182-8. PubMed ID: 22430201
[TBL] [Abstract][Full Text] [Related]
6. Antipsychotics in the management of behavioral and psychological symptoms of dementia: maximizing gain and minimizing harm.
Tampi RR; Tampi DJ; Rogers K; Alagarsamy S
Neurodegener Dis Manag; 2020 Feb; 10(1):5-8. PubMed ID: 32027552
[No Abstract] [Full Text] [Related]
7. Neonates and medicines: a roadmap to further improve neonatal pharmaceutical care.
Allegaert K; Sherwin C
Eur J Pediatr; 2016 Jun; 175(6):743-6. PubMed ID: 26744132
[No Abstract] [Full Text] [Related]
8. Antipsychotics and dementia in Canada: a retrospective cross-sectional study of four health sectors.
Rios S; Perlman CM; Costa A; Heckman G; Hirdes JP; Mitchell L
BMC Geriatr; 2017 Oct; 17(1):244. PubMed ID: 29061129
[TBL] [Abstract][Full Text] [Related]
9. A U.K. multicentre audit of the assessment and management of psoriasis in children.
Lam ML; Burden-Teh E; Taibjee SM; Taylor A; Webster S; Dolman S; Jury C; Caruana D; Darne S; Carmichael A; Natarajan S; McPherson T; Moore A; Katugampola R; Kalavala M; Al-Ismail D; Richards L; Jones V; Batul Syed S; Glover M; Hughes J; Anderson E; Hughes B; Babakinejad P; Murphy R
Br J Dermatol; 2015 Mar; 172(3):789-92. PubMed ID: 25308153
[No Abstract] [Full Text] [Related]
10. The A+KIDS Program.
Farley JF; Weeks L; Wegner SE
Psychiatr Serv; 2013 Jan; 64(1):98-9. PubMed ID: 23280465
[No Abstract] [Full Text] [Related]
11. Detecting and Managing Neuropsychiatric Symptoms in Dementia.
Iaboni A; Rapoport MJ
Can J Psychiatry; 2017 Mar; 62(3):158-160. PubMed ID: 28212493
[No Abstract] [Full Text] [Related]
12. Practice guidelines and combining atypical antipsychotics.
Wilf TJ
Am J Psychiatry; 2004 Sep; 161(9):1717-8. PubMed ID: 15337672
[No Abstract] [Full Text] [Related]
13. Audit of antipsychotic prescribing in dementia: Cambridgeshire results and lessons learnt.
Wightman R; Fielding J; Green S
Psychiatr Danub; 2011 Sep; 23 Suppl 1():S126-9. PubMed ID: 21894119
[TBL] [Abstract][Full Text] [Related]
14. Role of the prescribing observatory for mental health.
Barnes TR; Paton C
Br J Psychiatry; 2012 Dec; 201(6):428-9. PubMed ID: 23209087
[TBL] [Abstract][Full Text] [Related]
15. Risperidone for the treatment of behavioral disturbances in dementia: a case series.
Herrmann N; Rivard MF; Flynn M; Ward C; Rabheru K; Campbell B
J Neuropsychiatry Clin Neurosci; 1998; 10(2):220-3. PubMed ID: 9608413
[TBL] [Abstract][Full Text] [Related]
16. Antipsychotics and dementia: where do we go from here?
Blazer DG
J Am Med Dir Assoc; 2013 Apr; 14(4):307-8. PubMed ID: 23415842
[No Abstract] [Full Text] [Related]
17. EFFICIENCY. Getting through the barriers of variation.
Read C
Health Serv J; 2016 Feb; 126(6474):18-9. PubMed ID: 27089792
[No Abstract] [Full Text] [Related]
18. The efficacy and safety of atypical antipsychotics for the treatment of dementia: a meta-analysis of randomized placebo-controlled trials.
Ma H; Huang Y; Cong Z; Wang Y; Jiang W; Gao S; Zhu G
J Alzheimers Dis; 2014; 42(3):915-37. PubMed ID: 25024323
[TBL] [Abstract][Full Text] [Related]
19. Characteristics of antipsychotic medication prescribing on inpatient obstetric floors.
Johnson K; Muzyk A; Wald M
Arch Womens Ment Health; 2016 Aug; 19(4):705-7. PubMed ID: 27289483
[No Abstract] [Full Text] [Related]
20. Atypical antipsychotics for the treatment of dementia-related behaviors: an update.
Daiello LA
Med Health R I; 2007 Jun; 90(6):191-4. PubMed ID: 17633594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
